FDA Inspection
Abbott Laboratories GmbHAbbott Laboratories GmbH – FDA Inspection, Feb 24, 2017
Record Details
This FDA Inspection record concerns Abbott Laboratories GmbH, with an inspection on February 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 32c87f90-f0b1-41a2-9580-a85ead30b8cc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017658
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Abbott Laboratories GmbH
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 30, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 24, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 19, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 11, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Abbott Laboratories GmbH
- FDA Inspection 1274874 - 2024-05-30
- FDA Inspection 1107966 - 2019-08-30
- FDA Inspection 904481 - 2014-10-24
- FDA Inspection 830369 - 2013-04-19
- FDA Inspection 682154 - 2010-06-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.